Epoxyeicosatrienoic acids (EETs): Metabolism and biochemical function

Arthur A. Spector, Xiang Fang, Gary D. Snyder, Neal L. Weintraub

Research output: Contribution to journalReview article

401 Citations (Scopus)

Abstract

Epoxyeicosatrienoic acids (EETs), which are synthesized from arachidonic acid by cytochrome P450 epoxygenases, function primarily as autocrine and paracrine effectors in the cardiovascular system and kidney. They modulate ion transport and gene expression, producing vasorelaxation as well as anti-inflammatory and pro-fibrinolytic effects. EETs are incorporated into the sn-2 position of phospholipids and are rapidly mobilized when a cell is treated with a Ca 2+ ionophore, suggesting that they may play a role in phospholipid-mediated signal transduction processes. Soluble epoxide hydrolase (sEH) converts EETs to dihydroxyeicosatrienoic acids (DHETs), and inhibition of sEH is a potential approach for enhancing the biological activity of EETs. EETs also undergo chain-elongation and β-oxidation, and the accumulation of partial β-oxidation products increases when sEH is inhibited. Some functional effects of EETs occur through activation of either the guanine nucleotide binding protein Gαs or the Src signal transduction pathways, suggesting that EETs act by binding to membrane receptors. However, other evidence indicates that the modulation of gene expression occurs through an intracellular action of EETs. Because of the diversity of biochemical and functional responses produced by EETs, it is doubtful that a single mechanism or signal transduction pathway can account for all of their actions.

Original languageEnglish (US)
Pages (from-to)55-90
Number of pages36
JournalProgress in Lipid Research
Volume43
Issue number1
DOIs
StatePublished - Jan 1 2004
Externally publishedYes

Fingerprint

Epoxide Hydrolases
Signal transduction
Metabolism
Signal Transduction
Gene expression
Acids
Phospholipids
Gene Expression
Cardiovascular system
Oxidation
Guanine Nucleotides
Ionophores
Ion Transport
Cardiovascular System
Bioactivity
Arachidonic Acid
Vasodilation
Cytochrome P-450 Enzyme System
Elongation
Carrier Proteins

Keywords

  • Chain-elongation
  • Cytochrome P450
  • DHET
  • EDHF
  • EET
  • Epoxide hydrolase
  • Inflammation
  • Ion channels
  • Phospholipid
  • Receptor
  • β-Oxidation

ASJC Scopus subject areas

  • Biochemistry
  • Cell Biology

Cite this

Epoxyeicosatrienoic acids (EETs) : Metabolism and biochemical function. / Spector, Arthur A.; Fang, Xiang; Snyder, Gary D.; Weintraub, Neal L.

In: Progress in Lipid Research, Vol. 43, No. 1, 01.01.2004, p. 55-90.

Research output: Contribution to journalReview article

Spector, Arthur A. ; Fang, Xiang ; Snyder, Gary D. ; Weintraub, Neal L. / Epoxyeicosatrienoic acids (EETs) : Metabolism and biochemical function. In: Progress in Lipid Research. 2004 ; Vol. 43, No. 1. pp. 55-90.
@article{2e37d50df8c246b8baded017958bc738,
title = "Epoxyeicosatrienoic acids (EETs): Metabolism and biochemical function",
abstract = "Epoxyeicosatrienoic acids (EETs), which are synthesized from arachidonic acid by cytochrome P450 epoxygenases, function primarily as autocrine and paracrine effectors in the cardiovascular system and kidney. They modulate ion transport and gene expression, producing vasorelaxation as well as anti-inflammatory and pro-fibrinolytic effects. EETs are incorporated into the sn-2 position of phospholipids and are rapidly mobilized when a cell is treated with a Ca 2+ ionophore, suggesting that they may play a role in phospholipid-mediated signal transduction processes. Soluble epoxide hydrolase (sEH) converts EETs to dihydroxyeicosatrienoic acids (DHETs), and inhibition of sEH is a potential approach for enhancing the biological activity of EETs. EETs also undergo chain-elongation and β-oxidation, and the accumulation of partial β-oxidation products increases when sEH is inhibited. Some functional effects of EETs occur through activation of either the guanine nucleotide binding protein Gαs or the Src signal transduction pathways, suggesting that EETs act by binding to membrane receptors. However, other evidence indicates that the modulation of gene expression occurs through an intracellular action of EETs. Because of the diversity of biochemical and functional responses produced by EETs, it is doubtful that a single mechanism or signal transduction pathway can account for all of their actions.",
keywords = "Chain-elongation, Cytochrome P450, DHET, EDHF, EET, Epoxide hydrolase, Inflammation, Ion channels, Phospholipid, Receptor, β-Oxidation",
author = "Spector, {Arthur A.} and Xiang Fang and Snyder, {Gary D.} and Weintraub, {Neal L.}",
year = "2004",
month = "1",
day = "1",
doi = "10.1016/S0163-7827(03)00049-3",
language = "English (US)",
volume = "43",
pages = "55--90",
journal = "Progress in Lipid Research",
issn = "0163-7827",
publisher = "Elsevier Limited",
number = "1",

}

TY - JOUR

T1 - Epoxyeicosatrienoic acids (EETs)

T2 - Metabolism and biochemical function

AU - Spector, Arthur A.

AU - Fang, Xiang

AU - Snyder, Gary D.

AU - Weintraub, Neal L.

PY - 2004/1/1

Y1 - 2004/1/1

N2 - Epoxyeicosatrienoic acids (EETs), which are synthesized from arachidonic acid by cytochrome P450 epoxygenases, function primarily as autocrine and paracrine effectors in the cardiovascular system and kidney. They modulate ion transport and gene expression, producing vasorelaxation as well as anti-inflammatory and pro-fibrinolytic effects. EETs are incorporated into the sn-2 position of phospholipids and are rapidly mobilized when a cell is treated with a Ca 2+ ionophore, suggesting that they may play a role in phospholipid-mediated signal transduction processes. Soluble epoxide hydrolase (sEH) converts EETs to dihydroxyeicosatrienoic acids (DHETs), and inhibition of sEH is a potential approach for enhancing the biological activity of EETs. EETs also undergo chain-elongation and β-oxidation, and the accumulation of partial β-oxidation products increases when sEH is inhibited. Some functional effects of EETs occur through activation of either the guanine nucleotide binding protein Gαs or the Src signal transduction pathways, suggesting that EETs act by binding to membrane receptors. However, other evidence indicates that the modulation of gene expression occurs through an intracellular action of EETs. Because of the diversity of biochemical and functional responses produced by EETs, it is doubtful that a single mechanism or signal transduction pathway can account for all of their actions.

AB - Epoxyeicosatrienoic acids (EETs), which are synthesized from arachidonic acid by cytochrome P450 epoxygenases, function primarily as autocrine and paracrine effectors in the cardiovascular system and kidney. They modulate ion transport and gene expression, producing vasorelaxation as well as anti-inflammatory and pro-fibrinolytic effects. EETs are incorporated into the sn-2 position of phospholipids and are rapidly mobilized when a cell is treated with a Ca 2+ ionophore, suggesting that they may play a role in phospholipid-mediated signal transduction processes. Soluble epoxide hydrolase (sEH) converts EETs to dihydroxyeicosatrienoic acids (DHETs), and inhibition of sEH is a potential approach for enhancing the biological activity of EETs. EETs also undergo chain-elongation and β-oxidation, and the accumulation of partial β-oxidation products increases when sEH is inhibited. Some functional effects of EETs occur through activation of either the guanine nucleotide binding protein Gαs or the Src signal transduction pathways, suggesting that EETs act by binding to membrane receptors. However, other evidence indicates that the modulation of gene expression occurs through an intracellular action of EETs. Because of the diversity of biochemical and functional responses produced by EETs, it is doubtful that a single mechanism or signal transduction pathway can account for all of their actions.

KW - Chain-elongation

KW - Cytochrome P450

KW - DHET

KW - EDHF

KW - EET

KW - Epoxide hydrolase

KW - Inflammation

KW - Ion channels

KW - Phospholipid

KW - Receptor

KW - β-Oxidation

UR - http://www.scopus.com/inward/record.url?scp=0242720683&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0242720683&partnerID=8YFLogxK

U2 - 10.1016/S0163-7827(03)00049-3

DO - 10.1016/S0163-7827(03)00049-3

M3 - Review article

C2 - 14636671

AN - SCOPUS:0242720683

VL - 43

SP - 55

EP - 90

JO - Progress in Lipid Research

JF - Progress in Lipid Research

SN - 0163-7827

IS - 1

ER -